Back to Journals » Drug Design, Development and Therapy » Volume 11

Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date

Total article views   HTML views PDF downloads Totals
17,558 Dovepress* 11,948+ 1,525 13,473
PubMed Central* 5,610 1,268 6,878
Totals 17,558 2,793 20,351
*Since 2 November 2017
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 2 4

View citations on PubMed Central and Google Scholar